Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by fox7mf


T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

A +$10b usd buyout would be a lot easier to see if....Coffey, Parsons and...

June 14, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

Are these type deals, structured as you suggested, often seen? Very...

June 14, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

What I'm getting at, and it concerns me greatly, is how do we arrive at a...

June 14, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

So, how do we go from a $175m market cap to a $15b+ valuation? I mean in a...

June 13, 2023

T.ONC

RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

Let's hope they do their jobs in a timely manner from this point on...

June 13, 2023

T.ONC

RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

So Oncy goes from a $11b-$15b valuation to $5b-$10b? Let's start with...

June 13, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Who knows what ? When or how?

Pancreatic trial update will probably be end of October at ESMO and we'll...

June 13, 2023

T.ONC

RE:RE:Some numbers to chew on….Roche & onc

Who knows why we are waiting, but it's obvious patience is wearing thin...

June 13, 2023

T.ONC

RE:Volume and price moving

Over 6 times the average volume stateside, and if the volume continues to...

June 12, 2023

T.ONC

RE:RE:RE:Biotech M&A to Boom across a landscape of uncharted markets

I would sign off on an $24.9b deal. It just  better be more than...

June 11, 2023

T.ONC

Cantor Fitzgerald....

will host yet another biotech industry/analyst conference call today...

June 9, 2023

T.ONC

RE:BIO2023 conference currently in Boston MA.

Good point. They no longer have to present data to sell, having just...

June 8, 2023

T.ONC

RE:Licensure-Enabling Study

Yeah, I'm not sure of the term 'licensure enabling study' either....

June 6, 2023

T.ONC

RE:Hey everybody...don’t get fooled by stop loss raids....

Well said Angler. Nothing but huge positives for continuing negotiations. IND...

June 6, 2023

T.ONC

RE:RE:Oncy raised from $3 usd to $5 usd.

Bracelet is done. Bracelet is a success. Things, (FDA guidance, accelerated...

June 5, 2023

T.ONC

RE:Oncy raised from $3 usd to $5 usd.

These figures will be eclipsed several times over by our eventual and...

June 5, 2023

T.ONC

Oncy raised from $3 usd to $5 usd.

Jason McCarthy at Maxim Group raised Oncy's year end price forecast based...

June 5, 2023

T.ONC

RE:Hazard Ratio (HR)

Amazing success today. Those BP interested loved the hazard ratio of .29. I...

June 5, 2023

T.ONC

RE:RE:The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't

Maybe $ONCY is worth anywhere between $10b and $25b, but let's get...

June 3, 2023

T.ONC

ASCO is finally upon us.

We need the crew to come through with the promised unquestionably positive...

June 2, 2023